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Summary.-Moloney sarcoma-virus (MSV)-induced tumours in A/Sn mice have
been dispersed with collagenase and DNase 8-15 days after virus inoculation, and
both "sarcoma" and inflammatory cells separated by sedimentation velocity and
adherence techniques. The isolated "sarcoma" cells had the morphological charac-
teristics of atypical cells (i.e. cytoplasmic blebbing, vacuolization and prominent
nucleoli) and were easily adapted to in vitro growth. As few as 2 x 103 of these cells
inoculated i.m. produced new tumours within8 days ofinjection in bothsyngeneic and
allogeneic mice. Also, cell-free supernatant from "sarcoma"-cell cultures produced
tumours, indicating that the successful transplantation of the "sarcoma" cells was
probably due to production of infective virus. Cells cytotoxic in vitro against the
''sarcoma'' cells were present within both spleen and tumour of the tumour donors,
but not in the spleens of normal mice. The cytotoxicity was specific against virus-
infected cells, since in a mixture of virus-positive (gp 70) and virus-negative cells,
positive cells were removed while negative cells were not affected, as measured by a
visual cytotoxicity assay using immunostaining. Although T cells could be isolated
from the MSV-induced tumours, these cells did not appear to mediate the cytotoxicity
detected against the MSV "sarcoma" cells. These results suggest that early MSV
infections might be sensitive to cytotoxic mechanisms distinct from those reported
with established MLV- or MSV-induced tumour lines.
I.M. INJECTION of Moloney murine
sarcoma virus (MSV) leads to the develop-
ment of a tumour within 6-8 days. In
immunocompetent mice the tumour re-
gresses within 20 days. The nature of the
tumouris, however, subjectto controversy.
It has been classified as a true malignancy
(Perk & Moloney, 1966) as well as a repara-
tive granulomatous process (Stanton et al.,
1968; Siegler, 1970). The regression of the
lesion is T-cell-dependent (Law et al.,
1968; Gorezynski, 1974; Stutman, 1.975)
and cytotoxic T cells have been found in
lymphoid organs and blood as well as
within the tumour mass in C57BL and
BALB/c mice (Plata & Sordat, 1977;
Holden et al., 1976; Gillespie et al., 1977).
Thus cytotoxic T cells are considered to
play an important role in regression.
In the A/Sn mouse strain we have been
unable to demonstrate cytotoxic T cells
during MSV-induced tumour develop-
ment and regression, using syngeneic
established MLV-induced lymphoma lines
as target cells (Becker & Klein, 1976,
1980). As these cells neednotbe the correct
targets for the demonstration of cyto-
toxic T cells in this strain, though suitable
in other strains (Plata & Sordat, 1977;
Holden et al., 1976; Gillespie et al., 1977),
we made an effort to isolate the in vivo
target cells for the virus to use as in vitro
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targets in the cytotoxicity tests of the
inflammatory cells isolated from the
tumours. In this paper, we describe some
properties of the MSV "sarcoma"* cells
which qualify them as target cells for the
invitro testing. We demonstrate that cyto-
toxic effector cells with specificity for
virus-infected cells can be isolated, and
confirm our previous observation that
cytotoxic T cells need not be an effector
mechanism in regression.
MATERIALS AND METHODS
Animals and MISV tumour induction.-
Four-8-week-old mice of the inbred strains
A/Sn, (A/Sn xC57BL/6) F1 (G. Klein Tumor-
biology, Karolinska Institute) and B6D2F,
(Jackson Laboratory, Bar Harbor, Maine,
U.S.A.) of both sexes were used. Primary
MSV tumours were induced by i.m. injection
of 0 05 ml MSV extract (Moloney sarcoma
virus, supplied by Cancer Cause and Preven-
tion, National Cancer Institute, Bethesda,
Md.) into the left hind leg.
Medium.-Medium RPMI 1640 containing
10% heat-inactivated foeta] calf serum
(FCS) (BioCult, Glasgow) with penicillin
and streptomycin were used throughout the
experiments as diluent and culture media.
Target cell8.-RBL-5, a Rauscher leu-
kaemia virus-induced tumour in C57BL/6
carried in vitro was used in the 51Cr-release
test. "Sarcoma" cells isolated from MSV
induced tumours were used as target cells,
both in isotope-release cytotoxicity tests
and in the microcytotoxicity test.
Spleen cells.-Spleens were aseptically re-
moved and pressed gently through nylon
gauze. The clumps were allowed to sediment
and the cells washed and resuspended in
culture medium. Erythrocytes were lysed by
treatment with 0.83% NH4Cl for 10 min at
400.
MSV-Induced tumour suspensions.-MSV
tumours 10-1" days after MSV injection were
aseptically removed and the tumours were
sliced into small 2-3mm pieces. This material
was treated with 0-14% collagenase contain-
ing 0.05%0 DNase for 20 min, washed with
medium, and the process repeated until most
ofthe material was digested.
Sedimentation-velocity separation.-Suspen-
sions of the enzyme-dispersed tumours were
resuspended to 1.5 x 106 cells/ml in MEM
5% FCS and sedimented at unit gravity
over a continuous 10-25% FCS in MEM at
pH 7-4 for 2 h, as described by Miller and
Phillips (1969). Fractions were collected, and
cell counts made in a haemacytometer and
cytocentrifuge preparations made of each
fraction.
Removal of phagocytic cells.-Macrophages
were removed by incubation of 5 ml of cell
suspension withcarbonyl iron in 60mmplastic
Petri dishes (1007 Falcon Plastics, Oxnard,
CA). After incubation at 37°C for 30 min,
iron and iron-containing cells were removed
with a magnet. In some experiments, macro-
phages were removed by EA rosetting and
Ficoll-Hypaque separation as described pre-
viously (Becker & Haskill, 1980a).
Detection and removal of thymus-derived
BO+ cells.-T cells were removed by treat-
ment with rabbit anti-BO sera and comple-
ment (C). Both were obtained from Cedarlane
Laboratories (Scarborough, Ontario). Rabbit
anti BO sera was used at a final dilution of
1: 6 and complement at 1: 8. Forenumeration
of T cells, fluorescein-conjugated goat anti-
rabbit sera (Antibodies Inc., Davis, CA) was
used at a dilution of 1:4 instead of comple-
ment.
Detection of Fc receptor+ cells. Sheep erythrocytes (SRBC) were sensitized with
2 concentrations of anti-SRBC antibody, as
previously described (Korn et al., 1978). A
30-fold excess of either 1% suspension of
antibody-coated SRBC (EA) was centrifuged
for 5 min with the test population, resus-
pended and counted in a hemacytometer.
Tests have shown that an antibody level
about one-tenth that needed foragglutination
at 4°C can be used to prepare indicator
erythrocytes that predominantly detect
monocytes and macrophages. Fc receptor
(FcR)+ lymphocytes and granulocytes are
detected only with the lower dilutions of
antibody used forsensitization.
Isotope-release cytotoxicity assays.-For
51Cr-labelling the target cells (RBL-5 cells)
were incubated for 20-30 min at a concentra-
tion of 5-10 x 106 cells suspended in 0-3 ml
complete medium to which 100 ,uCi of 51Cr
as sodium chromate was added. The cells
were washed x 3 and adjusted to the desired
concentration. The freshly isolated MSV
* The torm "sarcoma" has been used tentatively to name the atypical cells isolated from the MSV-induced tumour.
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"sarcoma" cells were incubated for 20 h in
37°C before 51Cr was added. 2 x 106 cells in
0-1 ml media were labelled with 100 XCi
51Cr for 90 min, washed and adjusted to
the desired concentration. The assay was per-
formed in 3040 Microtest II culture plates
(Falcon Plastics, Oxnard, CA). To 0-2 ml of
various effector cell concentrations, we added
2 x 104 51Cr-labelled target cells in 0-02 ml.
Triplicate wells of each mixture were set up.
Target cells were incubated also without
effector cells to estimate the level of spon-
taneous 51Cr release, which varied between
18 and 250/ of total label for RBL-5 and
23-30% for the "sarcoma" cells. The tests
were incubated in 37°C 500 CO2 for 16 h.
Thereafter, the plates were centrifuged at
500 g for 5 min, 0-1 ml of the supernatant
w%-as removed into tubes, and the radioactivity
mwas measured in a y counter. Maximum
release was determined by treating the target
cells with distilled water overnight, which
released 80-900% oftotal 51Cr. The percentage
specific 51Cr release wAas calculated according
to the following formula:
0/0 specific release=
exp. release -spont. release
x 100
max. release -spont. release
Mllicrocytotoxicity test. 50-100 highly ad-
herent MSV "sarcoma" target cells wrere
plated in 10 ,ul ofcomplete media, and effector
cells in 10 ,ul wvere added to the microcyto-
toxicity test plates (3034 Falcon Plastic,
Oxnard, CA). The effector cells were adjusted
to 2 x 105, 105 and 5 x 104 cells/ml to give
approximate effector cell to target cell ratios
of 200: 1, 100:1 and 50: 1. Eight wells ofeach
effector:target mixture wAere done. The test
wias incubated in 37°C 50 CO2 for 16-18 h.
Thereafter, a 1% glutaraldehyde solution
wras poured over each tray and the cells were
allowed to fix for 15 min. This ensured that
even rounded-up target cells adhered to the
bottom of the well. The glutaraldehyde w,as
removed by rinsing in tap water and the cells
weres tained with dilute Giemsa solution. The
percentagetarget cellreductionwas calculated
by the following formula:
00 target cell reduction=
No. of cells with media alone -No. of
cells with effector cells
No. of cells with media alone x 100
Detection ofvirus-positive cells-.These cells
were detected by the immunoperoxidase
technique originally described by Mason
et al. (1969). Briefly, the cells were fixed in
ice-cold acetone or acetone: methanol (1:1)-
for 10 min, rinsed 30 min in PBS and incu-
bated with rabbit anti-gp7O serum kindly
provided by Dr D. Bolognesi, Duke Univer-
sity, Durham, N.C. This step was followed by
rinsing and incubation with the following
reagents, 10 min with each: goat anti-rabbit
IgG, dliuted 1: 20 (Cappel Laboratory, Cocha-
ranville, PA), rabbit anti-peroxidase, diluted
1:20 (Cappel) and horse radish peroxidase
(Sigma, St Louis, MO), 0-5 mg00 in PBS.
rinsing x3 in PBS between each step. The
reaction was visualized by 30 mg% diamino
benzidine in 0-5M Tris-HCl (pH 7.2) +0 0030%
H202. The slides were rinsed in water and
counterstained with methylgreen. The cyto-
plasm of virus+ cells stained an intense dark
brown.
Test for selective killing of virus-infected
"sarcoma" cells. Sarcoma cells (2 x 103) in
0 5 ml of complete medium were plated in
16mm culture plates (3524, Costar Cambridge,
Mass, U.S.A.). Effector cells isolated from the
MSV-induced tumour were added in 0 5 ml
at effector: target cell ratios of 100:1, 30:1
and 10:1. The test was incubated in 37°C,
500 CO2 for 40 h and terminated by gentle
rinsing of the wells with PBS followed by
fixation of adherent cells with methanol:
acetone (1:1) for ]0 min. The immuno-
peroxidase-bridge technique as described
above then allowed us to distinguish between
virus+ and virus- cells. To calculate the
relative numbers of positive and negative
cells a total of 25 high-powver fields from 4-5
identical wells were averaged.
RESULTS
Isolation and description of the cell types in
MSV-induced tumours
I.m. injection of A/Sn mice with our
MSV preparation produced tumours in
80% of the animals. Maximum size of the
lesion occurred around Day 12, after
which the tumour regressed, disappearing
completely within 20 days. Collagenase-
DNase dispersion of this tissue at Day 11
yielded about 40-60 x 106 cells per donor
containing a variety of inflammatory cells
including lymphocytes, macrophages,
monocytes, polymorphs, and a significant
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FIG. 1.-Sedimentation-velocity profile of
collagenase-DNase dispersed MSV primary
tumours (Day 11) (0). "Tumour" cells (C1)
and lymphocytes (0) were quantitated by
morphology on Giemsa-stained cytocentri-
fuge preparations. SRBC coated with high
dilutions of antibody were used to detect
phagoeytic macrophages (A) and lower
dilutions of antibody were used to coat
SRBC for total FcR-bearing cells (*).
Infiltrating fractions 3-5 mm/h contained
45% BO+ cells by immunofluorescence.
(Fn =Fraction).
13
number of cells with the histological
appearance oftransformed cells (3-4 x 106/
donor). Fig. 1 shows a sedimentation-
velocity profile of an A/Sn MSV-tumour
suspension. The different cell populations
have been characterized morphologically
on Giemsa-stained cytocentrifuge prepara-
tions, and by their rosetting ability with
different EA preparations, one detecting
total FcR+ cells, the other detecting
phagocytic macrophages (Korn et al.,
1978).
Characterization ofthepresumptive sarcoma
cells
Cells sedimenting at 8-12 mm/h con-
sisted of both large macrophages and
atypical cells (Fig. 1). EA rosetting of the
fractions showed that the atypical cells
did not express FcR (cytocentrifuge pre-
parations made on the rosetted material)
and thus could be purified from the
contaminating macrophages by Ficoll-
Hypaque separation of the rosetted
FiG. 2. Giemsa-stained cytocentrifuge preparation of MSV-induced tumour-derived target cells
directly upon isolation.
21
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material. The atypical cells could also be
separated from the macrophages by a
briefincubation (30 min) in carbonyl iron.
The purified "sarcoma" cells showed cyto-
plasmic blebbing and were frequently
highly vacuolated; the large nuclei had
prominent nucleoli (Fig. 2). After over-
night incubation in culture dishes or in
the microcytotoxicity test, these cells
were 90% homogeneous in gross morph-
ology and fibroblastic in appearance. The
plating efficiency varied from 10 to 30%.
After 24 h in culture, 25-35% of the
adherent "sarcoma" cells were highly
virus+, as determined by the immuno-
peroxidase-bridge technique (data not
shown). The purified "sarcoma" cells were
easily maintained in tissue culture.
To test the tumorigenicity ofthe freshly
isolated "sarcoma" cells, graded doses of
''sarcoma'' cells were injected into the
hind leg of A/Sn mice (Table I).
TABLE I.-Tumour incidence in mice
inoculated i.m. with graded numbers of
A/Sn "sarcoma" cells, or supernatant
from their 12h cultures
No. ofcells inoculated
(Table I). Thus, infective virus was re-
leased from the growing "sarcoma" cells.
Identification of cytotoxic effector cells
within the tumour
Since cell-mediated cytotoxic mech-
anisms presumably are important in the
regression ofMSV tumours, it was ofgreat
interest to see whetherin vitro cytotoxicity
could be demonstrated against the auto-
logous "sarcoma" target.
Various fractions of cells from the in-
filtrating cell populations described in
Fig. 1 were incubated with autologous
target cells in the 51Cr-release test, as well
as in the microcytotoxicity test for 18 h.
The representative results from 1 out of 4
such experiments performed are shown in
Fig. 3. Cytotoxicity of the autologous
"sarcoma") cells was seen in the low-
velocity fractions (2-4 mm/h, peak 3 mm/
h) with both assays. Since the microcyto-
toxicity test and the isotope test gave the
same result, microcytotoxicity was chosen
as standard assay in the experiments re-
ported below, due to the limited number
oftarget cells available.
Mouse
strain
A/Sn
B6 D2F,
2x 105
4/4
10/10
Super-
6 x 104 2 x 104 2 x 103 natant
3/3 10/10 4/10 11/15
10/10 5/5 4/6 N.D.
As few as 2 x 104 cells produced tumours
in 100% (10/10) of the injected mice,
whilst 2 x 103 cells gave tumours in 40%
(4/10) ofthe mice. Allogeneic B6D2F1 mice
were also injected with the A/Sn "sarc-
oma' cells and a similar tumour take was
observed (Table I). This is suggestive of
virus infection as the main, if not the only
source for tumour development. The
tumours induced with the "sarcoma" cells
regressed in both strains injected.
We also injected a set of mice with
0-2 ml cell-free supernatant collected from
overnight cultures of 2 x 106 "sarcoma"
cells cultured in 5 ml media. The super-
natant was also tumorigenic, as 73%
(11/15) of the mice developed tumours
50
o microcytotoxicity 0
o30
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FIG. 3.-Sedimentation-velocity profile of
anti-MSV-"sarcoma" cytotoxic activity
induced with various fractionsofinfiltrating
cells present in regressing MSV tumours
(Day 11) (A). Cytotoxicity was deter-
mined in the microcytotoxicity test (0) and
the 51Cr-release test (0) against "sarcoma"
cells obtained from the high-velocity frac-
tions (8-11 mm/h). The assays were carried
out at 100: 1 ratio ofeffector to target cells.
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A B
FIG. 4. Selective elimination of gp70+ cells in a microcytotoxicity test. A shows a well with virus+
cells unaffected by the low numbers of effector cells added (E: T ratio 2: 1). B shows a well where
the virus+ cells have been selectively removed by the effector cells (E: T ratio, 100: 1).
Demonstration ofselectivity in the killing of
''sarcoma" cells
The adherent "sarcoma" cells incubated
overnight consist of both strongly virus+
cells (30%) and cells which are completely
negative for virus as judged by the
immunoperoxidase-bridge technique. The
proportion and number of virus+ cells
increase upon in vitro culture (Becker &
TABLE II.-Selective cytotoxic influence of
the small inflammatory cells on the
autologous virus+ "sarcoma" cells*
Target
E:T 100:1 30:1 10:1 alone
% Virus+
cells/well 26-7 53-5 60-7 61-8
* Identified by the immunoperoxidase-bridge
technique.
Haskill, 1980b). To determine whether the
cytotoxic tumour-infiltrating cells selec-
tively kill virus+ cells, the immunoper-
oxidase-bridge method was used to stain
the assay wells. It was found that the
background staining was too high in the
microcytotoxicity test wells, so bigger
wells were used. In Fig. 4 such as assay is
shown: A shows a well with no cytotoxic
effect; in B the effector cells have killed
the virus+ cells and only negative cells
remain. Table II shows an experiment in
which different dilutions of effector cells
have been added to the wells and 25 high-
power fields counted after 40 h for their
content of virus+ and negative cells. The
data are expressed as the percentage of
virus+ cells in the total cells counted. In a
parallel experiment with the microcyto-
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TABLE III.-Cytotoxic activity against autologous sarcoma cells in spleen cellsfrom control
and immunosuppressed mice bearing MSV-induced tumours
% Cytotoxicity
I A \
Day 8
E:T 100:1 30:1
N spleen 3 (83+4)t 1 (85+4)
MSV spleen 27 (63± 2) 10 (77±2)
ALG-MSV spleen* 33 (57+1) 20 (68+1)
Media alone (86 ± 5)
Day 10
100:1 30:1
6 (81+4) 2 (84+3)
31 (59 + 4) 5 (81+ 1)
38(53+2) 3(83+1)
Day 13
100:1 30:1
2 (84+5) 2 (84+3)
42 (49 + 2) 15 (73 + 1)
29 (61+3) 10 (77+4)
* Mice given 0-25 ml anti-lymphocyte globulin Days -2, 0, 2 and 5. All tumours failed to regress.
t No. cells in the microcytotoxicity wells+ s.d.
toxicity assay, a clear cytotoxic effect was
seen with the inflammatory cells. How-
ever, a value for cytotoxicity could not be
obtained in the larger wells, owing to the
high number of target cells to be counted
and an uneven distribution of cells in the
wells, which made the comparison of total
cells per high-power field inaccurate.
Characterization of splenic activity against
autologous "sarcoma" cells
Spleen cells from control as well as
normal and anti-lymphocyte globulin
(ALG)-treated MSV tumour-bearing (8-13
days after virus inoculation) A/Sn mice
were tested against the autologous
"sarcoma" cells. Normal spleen cells had
no effect on the targets, whereas the
MSV spleens at all times after virus
inoculation markedly reduced the number
oftarget cells surviving in the tests (Table
III). Six experiments had similar results.
The MSV-spleen effect was not mediated
by cytotoxic T cells, as anti-BO and C
treatment of (A/Sn x C57BL/6) F1 MSV
TABLE IV.-Effect of anti-BO and
treatment on autologous cytotoxicity*
Infiltrating cells
(2-4 mm/h)
MSV spleen
N spleen
Media alone
35
(42 + I)t
17
(53+ 0)
0
(66 + 3)
(65 ± 1)
C alone
36
41 + 2)
15
(55 + 1)
N.D.
C
BO+C
40
(39 +1)
19
(52 + 3)
N.D.
* Effector: target ratio 100: 1 before any treat-
ment.
t No. cells in the microcytotoxicity wells + s.d.
tumour-bearer spleen cellscontaining cyto-
toxic T cells showed the expected reduc-
tion in activity against the T-cell-sensitive
RB1-5 lymphoma in the 51Cr-release test
(data not shown; Becker & Klein, 1980).
Characterization of in situ activity against
autologous "sarcoma" targets
The slow-sedimenting fractions (2-4
mm/h) active against autologous "sarc-
oma" cells (Fig. 3) were pooled and the
possible presence of cytotoxic T cells was
assessed by treating the cells either with
anti-BO serum and C or with medium and
C. This treatment did not affect the re-
duction of "sarcoma" target cells with
either MSV-spleen cells orinfiltrating cells.
Table IV shows one representative ex-
periment of the 5 done.
DISCUSSION
Histological data on MSV tumours
indicate that the cell types and tissue
organization of these lesions are con-
tinuously and progressively changing. At
the site of injection, an intense inflam-
matory response takes place, the lesion
containing varying proportions of neutro-
phils, macrophages, lymphocytes and
granulomatous tissue involving histio-
cytes, fibroblasts and scattered large
atypical cells of sarcoma morphology
(Berman & Allison, 1969; Stanton et al.,
1968; Siegler, 1970). Under conditions of
immunosuppression, the lesion continues
to expand until the host dies, thus sup-
posedly proving the malignant nature of
the tumour.
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The systemic immunity in MSV tumour
bearers has been thoroughly investigated
and the literature reviewed by Levy &
Leclerc (1977). Several laboratories have
tried to relate the systemic studies to the
host response within the tumour, in an
attempt to identify the important effector
mechanisms responsible for regression.
Cytotoxic T cells (Plata & Sordat, 1977;
Holden et al., 1976; Gillespie et al., 1977;
Chapdelaine et al., 1979), cytolytic mac-
rophages and cytostatic macrophages
(Puccetti & Holden, 1979; Russell et al.,
1977) have been isolated from enzyme-
dispersed tumours induced both by MSV
and by the MSC tumour line established
from an MSV-induced sarcoma. Studies
carried out on both systemic and intra-
tumoral immunity to MSV in A/Sn mice,
however, indicated that cytotoxic T cells
are not induced in this strain, suggesting
that cytotoxic T cells might not be essen-
tial for the regression of MSV-induced
tumours (Becker & Klein, 1976, 1980).
To date, all the studies on in situ
immunity to MSV have used established
MLV lymphoma or MSV sarcoma lines as
targets. In the present study, considering
the controversial nature of the lesion, the
possible ambiguities associated with the
use of long-term established lines have
been removed by the isolation of both
target cells (the presumptive sarcoma
cells) and the effector cells from the same
regressing MSV-induced tumour.
The tumour-isolated target cells were
morphologically abnormal. They showed
cytoplasmic blebbing, vacuolization and
prominent nucleoli, criteria which have
been used to characterize transformed
cells. In addition, they were nonphago-
cytic and did not express Fc receptors.
Non-cultured "sarcoma" cells, and super-
natants from 1-day cultures of "sarcoma"
cells, induced tumours when injected into
syngeneic as well as allogeneic mice.
These results strongly suggest that re-
infection of the second host is a very
important mechanism in the successful
"transplantation" of the lesion, and thus
supports the notion of Simons (1970) that
the MSV-induced tumour is a benign
reparative response against a highly
noxious virus. Further characterization of
the nature of the "sarcoma" cells and the
tumours they induce (Becker & Haskill,
1980b) indicated the nontransformed
nature ofthese cells.
The high infectivity of the MSV-
"sarcoma." cells renders them very im-
portant target cells for the host defence
mechanisms. In this report, we have
focused our interest on lymphoid-size
inflammatory cells, since cytotoxic T cells
have been implied to be of major import-
ance in the elimination of virus-infected
cells (Zinkernagel, 1979). Also, we wanted
to re-examine our previous conclusion
(Becker & Klein, 1980) that cytotoxic T
cells are not generated in response to MSV
in the A/Sn strain. Inflammatory cells
isolated from the MSV-induced tumours
with cytotoxic activity against the
"sarcoma"' cells were detected in the slow
sedimenting fractions (2-4 mm/h) known
to contain cytotoxic T cells in C57BL-6
MSV sarcomas (Holden et al., 1976). This
fraction consisted of small lymphocyte-
like cells and granulocytes as determined
by morphology on cytocentrifuge prepara-
tions. Although about 40% of these were
T cells, this population was not respons-
ible for the cytotoxicity of the autoch-
thonous target cells. Thus, our previous
observations, based on lack of cytotoxic
T cells against an MLV-induced lymphoma
line, hold also for the autologous MSV-
infected target cells (Becker & Klein,
1980). It is presumed that this reflects the
unimportance of cytotoxic T cells in the
defence against the in vivo infected, MSV-
producing cells responsible for propagation
ofthe lesion.
The in situ effector cells are selectively
cytotoxic against the virus-infected
"sarcoma"' cells. Non-infected (gp7O nega-
tive) presumably reparative fibroblasts in
the purified "sarcoma" cell population are
not affected in the cytotoxicity assay.
Induced NK cells have been shown
preferentially to kill transformed target
cells, though normal cells can be suscept-
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ible also (Welsh et al., 1979; Nunn et al.,
1977). The possibility that NK cells
mediate the cytotoxicity has been in-
vestigated by comparing the activity pro-
files on lg-sedimented tumour material
against the syngeneic lymphoma line,
YAC-1, a highly NK-sensitive target, and
the autologous MSV-infected cells. Al-
though the anti-YAC-1 activity in the
A/Sn mice (NK-low-reactive strain) is
very low, the weak activity was shown to
peak at 4*5 mm/h, while the autologous
activity peaked at 3 mm/h (Haskill &
Becker, 1979). This suggests that NK cells
are not responsible for the effect, but con-
sideration will be given to their possible
importance in our further attempts to
identify the active cells.
Macrophages have been shown specific-
ally to kill virus-infected cells (Goldman &
Hogg, 1978; Chapes & Tompkins, 1979).
Cytotoxic macrophages against lymphoma
cells have been identified in MSV-induced
tumours (Puccetti & Holden, 1979). Our
higher-velocity fractions contained macro-
phages. Although these macrophage cell
fractions were inactive in the 16h 51Cr-
release or microcytotoxicity experiments
(Fig. 2) we have been able to show that
these cells exert both cytostatic and cyto-
lytic effects against the autologous
"sarcoma" cells in 48h assays (Becker &
Haskill, 1980b).
These results, although not conclusively
identifying the active cells in the slow-
sedimenting fractions, do provide strong
evidence that the in vivo MSV-infected
cells are destroyed by effector cells differ-
ent from cytotoxic T cells. Recently
Leclerc & Cantor (1980) showed that
immune Ly 2 3-positive lymphocyte (cyto-
toxic and memory cells) did not protect
mice against MSV-induced tumours, but
did protect them against MLV lymphoma
growth. Ly 1 cells (helper and DHR cells)
on the other hand prevented sarcoma
formations. Therefore we believe that
MSV tumours, though dependent on an
intact thymus-dependent immune system,
presumably can regress in the absence of
cytotoxic T cells.
This work was supported by ACS Grant IM-84
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